After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MLYS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Mineralys Therapeutics Inc is $841.25M. A total of 0.85 million shares were traded on the day, compared to an average of 1.07M shares.
In the most recent transaction, Levy Adam Scott bought 10,757 shares of MLYS for 12.06 per share on Apr 11 ’25. In a previous transaction on Apr 11 ’25, Congleton Jon bought 15,319 shares at 12.19 per share.
Among the insiders who sold shares, Rodman David Malcom disposed of 55,771 shares on Apr 01 ’25 at a per-share price of $15.76. This resulted in the Chief Medical Officer holding 116,704 shares of MLYS after the transaction. In another insider transaction, Rodman David Malcom bought 55,771 shares at $15.76 per share on Apr 01 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MLYS has a high of $18.38 and a low of $8.24.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MLYS’s latest balance sheet shows that the firm has $10.61M in Cash & Short Term Investments as of fiscal 2021. There were $4.50M in debt and $5.05M in liabilities at the time. Its Book Value Per Share was $3.84, while its Total Shareholder’s Equity was -$22.93M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MLYS is Buy with a score of 5.00.
